|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 177.88 USD | +2.25% |
|
+9.86% | -21.09% |
| 03-04 | Glenmark Pharmaceuticals Gets US FDA Nod for Fluticasone Propionate Inhalation Aerosol | MT |
| 03-03 | IQVIA Seen Benefiting From Clinical Trial Rebound Through 2026 on AI Strength, RBC Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IQVIA HOLDINGS INC. | Other Biotechnology & Medical Research | +2.25% | +9.86% | -21.09% | -3.10% | -4.66% | 29.86B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- IQV Stock
- Charts Iqvia Holdings Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition